Trade Setup Buy Target $451.30 Sell Target $503.82 Zoom Video Communications, Inc. provides a video-first communications platform in the Americas, the Asia Pacific, Europe, the Middle East, and Africa. The company’s product portfolio includes Zoom Meetings that offers HD video, voice, chat, and content sharing through mobile devices, desktops, laptops, telephones, and conference room systems. […]
Read MoreTrade Setup Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer. Stocks found in this category are low priced stocks priced between […]
Read MoreTrade Setup Yunhong CTI Ltd. develops, produces, distributes, and sells consumer products in the United States and internationally. The company offers novelty products, including foil balloons; latex balloons under the Partyloons name; and toy balloon products, which include punch balls, water bombs, and Animal Twisties, as well as other inflatable toy items. Stocks found in […]
Read MoreBuy Price: $13.00 or better Sell Price: TradersPro Sell Signal Altimmune, Inc., a clinical stage biopharmaceutical company, focused developing treatments for liver disease, immune modulating therapies, and vaccines. The company develops HepTcell, an immunotherapeutic product candidate that has completed Phase I clinical trial for patients chronically infected with the hepatitis B virus; NasoShield, an anthrax […]
Read MorePlus, the U.S. surpassed 15 million coronavirus cases, Lowe’s said it expects sales to grow by 22% next year, and DoorDash sold 33 million shares at $102 a piece in its IPO.
Read MoreSometimes, answering the question of whether a stock represents a legitimate, attractive value opportunity can be hard to do. A company could be struggling not only to grow its business, but may be forced to restructure its business in a way that makes most of the traditional measurables investors like to use look very unfavorable. […]
Read More